G2212 — Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or

What the market charges

Across 947 negotiated rates, the middle 80% fall between $26 and $76, with a median of $38.

What Medicare pays

Medicare allowed an average of $31 for this code, across 640,930 services billed by 9,117 providers. At the median, the market charges 1.2 times what Medicare pays for this code.

Where this is billed, and what it costs there

The states billing G2212 most, by Medicare service volume, each compared against the national average of $31. Each links to the providers Mishe lists there.

• California — 1,387 providers billed it, Medicare allowed $34 — 10% above the national average
• Massachusetts — 506 providers billed it, Medicare allowed $32 — 3% above the national average
• Minnesota — 559 providers billed it, Medicare allowed $29 — 6% below the national average
• Florida — 425 providers billed it, Medicare allowed $31 — level with the national average
• New York — 451 providers billed it, Medicare allowed $33 — 6% above the national average
• Texas — 372 providers billed it, Medicare allowed $31 — level with the national average
• Maryland — 317 providers billed it, Medicare allowed $32 — 3% above the national average
• Illinois — 419 providers billed it, Medicare allowed $32 — 3% above the national average

Claim-editing rules

These are National Correct Coding Initiative procedure-to-procedure edits — the rules a payer applies when deciding whether two codes billed together are both payable.

Codes this one absorbs

Billed together, G2212 is the payable code and these are not separately payable. 6 pairs in total.

• 99358 — a modifier may allow both to be paid
• 99359 — a modifier may allow both to be paid
• 99415 — a modifier may allow both to be paid
• 99416 — a modifier may allow both to be paid
• 99417 — no modifier can override this edit
• 99418 — a modifier may allow both to be paid

Other codes

• J2777 — Injection, faricimab-svoa, 0.1 mg
• J0897 — Injection, denosumab, 1 mg
• J9271 — Injection, pembrolizumab, 1 mg
• J0129 — Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
• G0008 — Administration of influenza virus vaccine
• G0439 — Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit
• J9144 — Injection, daratumumab, 10 mg and hyaluronidase-fihj
• J9299 — Injection, nivolumab, 1 mg
• J1745 — Injection, infliximab, excludes biosimilar, 10 mg
• J2357 — Injection, omalizumab, 5 mg

Deploy this for your team

Every figure on this page came from published payer and Medicare data, assembled by Mishe. The same pricing, claim-editing and care-pathway intelligence runs underneath the plans Mishe operates.

• Contact Mishe to learn how to deploy these resources for your team
• Guides to direct-pay healthcare
• Cash prices by procedure
• Find a provider by state

Take back healthcare.